(Q53663711)

17 May 2018

title

Number needed to treat: easily understood and intuitively meaningful? Theoretical considerations and a randomized trial. (English)

1 reference

17 May 2018

author name string

Ivar Sønbø Kristiansen

1

1 reference

17 May 2018

Dorte Gyrd-Hansen

2

1 reference

17 May 2018

Jørgen Nexøe

3

1 reference

17 May 2018

Jesper Bo Nielsen

4

1 reference

17 May 2018

publication date

1 September 2002

1 reference

17 May 2018

Journal of Clinical Epidemiology

published in

1 reference

17 May 2018

volume

55

1 reference

17 May 2018

issue

9

1 reference

17 May 2018

page(s)

888-892

1 reference

17 May 2018

An assessment of clinically useful measures of the consequences of treatment

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900432-8

7 January 2021

The number needed to treat: a clinically useful measure of treatment effect

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900432-8

7 January 2021

Meaningful interpretation of risk reduction from clinical drug trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900432-8

7 January 2021

'Unqualified success' and 'unmitigated failure': number-needed-to-treat-related concepts for assessing treatment efficacy in the presence of treatment-induced adverse events.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900432-8

7 January 2021

Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900432-8

7 January 2021

Using numerical results from systematic reviews in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900432-8

7 January 2021

Adjusting the number needed to treat: incorporating adjustments for the utility and timing of benefits and harms

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900432-8

7 January 2021

Number needed to screen: development of a statistic for disease screening.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900432-8

7 January 2021

Cost-effectiveness of self-management in asthmatics: a 1-yr follow-up randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900432-8

7 January 2021

Completeness of reporting trial results: effect on physicians' willingness to prescribe

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900432-8

7 January 2021

Absolutely relative: how research results are summarized can affect treatment decisions

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900432-8

7 January 2021

Evidence based purchasing: understanding results of clinical trials and systematic reviews

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900432-8

7 January 2021

Communicating the benefits of chronic preventive therapy: does the format of efficacy data determine patients' acceptance of treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900432-8

7 January 2021

Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900432-8

7 January 2021

The 'number needed to treat' and the 'adjusted NNT' in health care decision-making.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900432-8

7 January 2021

Secondary prevention for ischemic heart disease. Relative numbers needed to treat with different therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900432-8

7 January 2021

Implications of trial results: the potentially misleading notions of number needed to treat and average duration of life gained

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900432-8

7 January 2021

Numbers needed to treat derived from meta-analyses--sometimes informative, usually misleading

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900432-8

7 January 2021

Number needed to treat: a useful new method of assessing the magnitude of treatment effect and its application to the management of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900432-8

7 January 2021

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900432-8

7 January 2021

Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900432-8

7 January 2021

10.1016/S0895-4356(02)00432-8

Identifiers

DOI

1 reference

17 May 2018

1 reference

17 May 2018